CY 208-243
Names
Biological Activity
[Description]:
CY 208-243 is a selective dopamine D1 receptor agonist which exhibits antiparkinsonian activity[1].
[Related Catalog]:
[Target]
dopamine D1 receptor[1]
[In Vivo]
Pretreatment with CY 208-243 (2.5 mg/kg; s.c.) prevents the increase of DA release and metabolism induced by the D-1 antagonist, SCH 23390 (0.05 mg/kg; s.c.)[1]. Animal Model: Male Sprague-Dawley rats (180-200 g)[1] Dosage: 2.5 mg/kg Administration: Subcutaneous Result: Prevented the increase of DA release and metabolism induced by the D-1 antagonist.
[References]
Chemical & Physical Properties
[ Density]:
1.225 g/cm3
[ Boiling Point ]:
466.5ºC at 760 mmHg
[ Melting Point ]:
227-228ºC
[ Molecular Formula ]:
C19H18N2
[ Molecular Weight ]:
274.36000
[ Flash Point ]:
236ºC
[ Exact Mass ]:
274.14700
[ PSA ]:
19.03000
[ LogP ]:
3.60780
[ Vapour Pressure ]:
7.02E-09mmHg at 25°C
[ Index of Refraction ]:
1.697